KBIO : Summary for KALOBIOS PHARMACEU COM USD0.001 - Yahoo Finance

U.S. Markets closed

KaloBios Pharmaceuticals, Inc. (KBIO)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.70-0.03 (-1.10%)
At close: 2:45PM EDT
People also watch
CANFPBMDMCURSPHSAEZS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.73
Open2.79
Bid0.00 x
Ask0.00 x
Day's Range2.70 - 2.79
52 Week Range1.90 - 5.21
Volume7,204
Avg. Volume11,684
Market Cap40.44M
Beta4.15
PE Ratio (TTM)-0.97
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire17 days ago

    Benznidazole on Track in Progress to IND and NDA Submissions

    Investigational new drug application on track to be submitted in May 2017 Manufacturing preparations in line to produce tablets, clinical batches produced Company anticipates filing new drug application ...

  • GlobeNewswire24 days ago

    KaloBios to Participate in Inaugural U.S. Chagas Conference

    BRISBANE, Calif., March 30, 2017-- KaloBios Pharmaceuticals, Inc., a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced that Cameron Durrant, ...

  • GlobeNewswire27 days ago

    KaloBios Receives M&A Advisor 2017 Turnaround Award

    BRISBANE, Calif., March 27, 2017-- KaloBios Pharmaceuticals, Inc., a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced today that it has ...